Manolo Bellotto

GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.

Aptitude Health LLC is a healthcare company based in Atlanta, GA. The company is the market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. The company's team of experts has a proven track record of success and is backed by unparalleled access to disease-state experts and healthcare professionals. Aptitude Health is dedicated to transforming the world's growing scientific and clinical knowledge into better cancer patient outcomes. The company was founded by Alexei Rojanets, who has been the CEO since incorporation.

The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Chemo SA is an Argentinean company that produces pharmaceuticals.